North Brunswick, NJ – From the company that has brought you over 40 years of excellence in laboratory pharmaceutical instruments, Distek, Inc. is proud to introduce the BIOne 1250 Bioprocess Control Station.
Distek, Inc. has revolutionized benchtop scale bioreactors with the release of our BIOne 1250 bioprocess control station for both mammalian and microbial models. The sleek appearance and intuitive touchscreen interface are only the beginning. The BIOne controller can seamlessly transition between traditional glass reactors and our BIOne single-use system.
“Our expansion into the biotech arena marks another major milestone in Distek’s longstanding company history. The BIOne 1250 offers an innovative approach to greatly assist our biotech customers,” says Jeff Brinker, President of Distek.
Easy to use, the BIOne bioprocess control station is powerful enough to develop processes at the benchtop scale. Designed to fit your needs, the BIOne controller can be customized to conform to your lab design...rotameters or auto flow control, left or right-side setup, optical pH or standard, smart sensors or standard sensors and much more.
“The release of the BIOne 1250 controller will establish Distek as an innovator in the benchtop bioreactor space and quickly establish Distek as a key player,” says Jeff Seely, Vice President of Sales & Business Development, Distek, Inc.
To learn more about the BIOne 1250 Bioprocess Control Station, contact Distek’s Corporate Office at +1 732 422 7585, by email at [email protected] or visit www.distekinc.com.
ABOUT DISTEK, INC.
Distek, Inc. is a leading manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry for over 40 years, as well as an experienced provider of validation and qualification services. Distek engineers highly innovative, technically modern and user-friendly instruments that provide many innovative features to customers, worldwide. Distek’s bioprocessing portfolio includes the BIOne single-use bioreactor for cell culture applications, as well as an innovative bioreactor control system for both mammalian and microbial models. Distek’s core market includes brand name and biosimilar manufacturers, CRO’s, CMO’s, government agencies and universities. Distek holds several instrumentation and accessory patents and has been ISO certified since 2002. For technological advancements that offer reliable and consistent performance, the biotech industry trusts Distek.